# Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

> **NCT04947683** · — · COMPLETED · sponsor: **Latin American Cooperative Oncology Group** · enrollment: 101 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04947683
- **Lead sponsor:** Latin American Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-06
- **Primary completion:** 2023-02-14
- **Final completion:** 2023-03-03
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947683, "Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04947683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*